Cefixime: Difference between revisions
Gloria Picoy (talk | contribs) No edit summary |
Gloria Picoy (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{DrugProjectFormSinglePage | {{DrugProjectFormSinglePage | ||
|authorTag={{GP}} | |||
|genericName=Cefixime | |||
|aOrAn=a | |||
|indicationType=treatment | |||
|indication=uncomplicated urinary tract infections, otitis media, pharyngitis and tonsillitis, acute exacerbations of chronic bronchitis and uncomplicated Gonorrhea. | |||
|adverseReactions=diarrhea, nausea, loose stools, abdominal pain, dyspepsia and vomiting. | |||
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b> | |blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content) | |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content) | ||
Revision as of 16:59, 9 January 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gloria Picoy [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Cefixime is a {{{drugClass}}} that is FDA approved for the treatment of uncomplicated urinary tract infections, otitis media, pharyngitis and tonsillitis, acute exacerbations of chronic bronchitis and uncomplicated Gonorrhea.. Common adverse reactions include diarrhea, nausea, loose stools, abdominal pain, dyspepsia and vomiting..
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
There is limited information regarding Cefixime FDA-Labeled Indications and Dosage (Adult) in the drug label.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Cefixime in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Cefixime in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Cefixime FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Cefixime in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Cefixime in pediatric patients.
Contraindications
There is limited information regarding Cefixime Contraindications in the drug label.
Warnings
There is limited information regarding Cefixime Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Cefixime Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Cefixime Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Cefixime Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Cefixime in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Cefixime in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Cefixime during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Cefixime in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Cefixime in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Cefixime in geriatric settings.
Gender
There is no FDA guidance on the use of Cefixime with respect to specific gender populations.
Race
There is no FDA guidance on the use of Cefixime with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Cefixime in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Cefixime in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Cefixime in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Cefixime in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Cefixime Administration in the drug label.
Monitoring
There is limited information regarding Cefixime Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Cefixime and IV administrations.
Overdosage
There is limited information regarding Cefixime overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Cefixime Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Cefixime Mechanism of Action in the drug label.
Structure
There is limited information regarding Cefixime Structure in the drug label.
Pharmacodynamics
There is limited information regarding Cefixime Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Cefixime Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Cefixime Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Cefixime Clinical Studies in the drug label.
How Supplied
There is limited information regarding Cefixime How Supplied in the drug label.
Storage
There is limited information regarding Cefixime Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Cefixime |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Cefixime |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Cefixime Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Cefixime interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Cefixime Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Cefixime Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [4]
Overview
Cefixime (Suprax in the USA )is a cephalosporin antibiotic used to treat bacterial infections. The bactericidal action of cephalosporin due to the inhibition of cell wall synthesis. It binds to one of the penicillin binding proteins (PBPs) which inhibits the final transpeptidation step of the peptidoglycan synthesis in the bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.
Category
Antibacterial
US Brand Names
Suprax®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages